Weitz Value Fund TECH trades
Wallace Weitz
Wallace Weitz Bio-Techne Corp stake
total: 54
Trades details
- Total transactions:
- 3
- New positions:
- 1
- Reduced:
- 2
- Held since:
- 2025 Q1
- Held for:
- 6 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Wallace Weitz holds 200,000 Bio-Techne Corp (TECH) shares with a market value of roughly $14.13M accounting for 2.26% of the overall portfolio. To date, the estimated cost basis is nearly $58.63 for "buy" trades and estimated average "sell" price is $60.54. Weitz Value Fund first purchased TECH in 2025 Q1, initially acquiring 300,000 shares. Since the initial investment in Bio-Techne Corp (TECH), Weitz Value Fund has made 2 more transactions.
When did Wallace Weitz buy Bio-Techne Corp (TECH)?
Wallace Weitz first invested in Bio-Techne Corp (TECH) in 2025 Q1 at the reported quarter-end price of $58.63 per share.
What's the cost basis of Weitz Value Fund's TECH stake?
The estimated cost basis for Bio-Techne Corp (TECH) stake is around $58.63 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $58.63
- Weighted AVG sell price:
- $60.54
Wallace Weitz's historical trades in Bio-Techne Corp
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.26%
|
200,000
|
$70.65
|
$14,130,000
|
-18.37% (-45,000)
|
-0.51%
|
|
2026 Q1
|
2.04%
|
245,000
|
$52.26
|
$12,803,700
|
-18.33% (-55,000)
|
-0.38%
|
|
2025 Q1
|
2.05%
|
300,000
|
$58.63
|
$17,589,000
|
new
|
+2.05%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.